期刊文献+

复发卵巢癌患者生命质量的研究进展 被引量:7

Quality of Life for Patients with Recurrent Ovarian Cancer
下载PDF
导出
摘要 绝大多数卵巢癌患者初诊时已属中晚期,并将面临复发,复发后患者的生命质量将明显下降。目前认为,复发卵巢癌患者的生命质量主要受到疾病本身及相关治疗的影响。例如肿瘤复发引起的肠梗阻、胸腹水等症状,脏器切除导致的并发症以及化疗带来的不良反应等,从多方面影响了患者正常的生理功能。此外,因治疗产生的脱发、性功能减退等不良结局以及对预后的担忧都将引起患者的负面情绪,从而降低生活质量。如何同时提高患者的生存与生命质量已成为复发卵巢癌的治疗目标。 Most patients with ovarian cancer were diagnosed at the advanced stages, and would eventually recur. The quality of life (QOL)of these patients will be diminished while experiencing recurrence. Generally, the QOL of patients with recurrent ovarian cancer is affected by disease itself and treatment. Many physiological functions are changed owing to the recurrent symptoms, such as bowel obstruction, ascites and pleural effusion, the postoperative complications of cytoreductive surgery, and the side-effects of chemotherapy. Besides, the psychological distress caused by bad endings of treatment, such as alopecia, and sexual dysfunction, and fear of poor prognosis, will result in lower QOL. The therapeutic goals for patients with recurrent ovarian cancer should be aimed to imlarove their both survivals and OOL.
作者 邵株燕 张平
出处 《国际生殖健康/计划生育杂志》 CAS 2013年第3期218-221,共4页 Journal of International Reproductive Health/Family Planning
基金 浙江省医药卫生科技计划项目(2012KYB031)
关键词 卵巢肿瘤 复发 生活质量 抗肿瘤联合化疗方案 治疗 Ovarian neoplasms Recurrence Quality of life Antineoplastic combined chemotherapyprotocols Therapy
  • 相关文献

参考文献28

  • 1Pearce NJ,Sanson-Fisher R, Campbell HS. Measuring quality of life in cancer survivors:a methodological review of existing scales [J]. Psychooncology, 2008,17(7 ) : 629-640.
  • 2Bristow RE,Puri I, Chi DS. Cytoreductive surgery for recurrent ovarian cancer:a meta-analysis[J]. Gynecol Oncol, 2009,112( 1 ) : 265-274.
  • 3Tebes SJ, Sayer RA, Palmer JM,et al. Cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma[J]. Gynecol Oncol,2007,106(3) :482-487.
  • 4Magtibay PM,Adams PB,Silverman MB,et al. Splenectomy as part of cytoreductive surgery in ovarian cancer[J]. Gynecol Oncol, 2006,102(2) : 369-374.
  • 5Roh HJ,Kim DY,Joo WD,et al. Hepatic resection as part of secondary cytoreductive surgery for recurrent ovarian cancer involving the liver [J]. Arch Gynecol Obstet, 2011,284(5 ) : 1223- 1229.
  • 6Dowdy SC,Loewen RT,Aletti G,et al. Assessment of outcomes and morbidity following diaphragmatic peritonectomy for women with ovarian carcinoma [J]. Gynecol Oncol, 2008,109( 2 ) : 303-307.
  • 7yon Gruenigen VE,Frasure HE,Jenison EL,et al. Longitudinal assessment of quality of life and lifestyle in newly diagnosed ovarian cancer patients: the roles of surgery and chemotherapy [J]. Gynecol Oncol, 2006,103( 1 ) : 120-126.
  • 8Krouse R,Grant M,Ferrell B,et al. Quality of life outcomes in 599 cancer and non-cancer patients with colostomies[J]. J Surg Res, 2007,138( 1 ) : 79-87.
  • 9Hilarius DL,Kloeg PH,van der Wall E,et al. Chemotherapy-induced nausea and vomiting in daily clinical practice:a community hospital-based study[J]. Support Care Cancer,2012,20( 1 ) : 107- 117.
  • 10Ocean A J, Vahdat LT. Chemotherapyinduced peripheral neuropathy: pathogenesis and emerging therapies[J]. Support Care Cancer,2004, 129(9) :619-625.

同被引文献54

引证文献7

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部